METTL3 maintains the expression of the CSC marker SRY-box 2 (SOX2) through the m6A–IGF2BP2-dependent regulatory mechanism in CRC cells and then promotes CRC stemness and metastasis [78] (Figure 4). The gene discussed is IGF2BP2; the disease is colorectal carcinoma.